Mr. Brady is a Stanford GSB Leader and focused on biomedical and Biopharma verticals. He launched the Saudi operation in May 2022 for Flow Pharma. He is a swimmer, life science investor and principal in management consulting at Sojo Consulting in the USA and the Middle East.